A Study of a Live Intranasal Influenza Vaccine in Children With Cancer

Completed · Phase 1

Conditions studied: Cancer

In brief

Eligible research subjects will be randomized to receive either FluMist or inactivated influenza vaccine then stratified by age and necessity to receive either one or two immunizations. Subjects requiring one immunization will be immunized at Day 0. Subjects requiring two immunizations will be immunized at Day 0 and Day 28. Subjects will be observed for 30 minutes following vaccination and given a diary card to record symptoms after each vaccination.

Key facts

Study ID
NCT00906750
Run by
St. Jude Children's Research Hospital
People needed
56
Starts
2008-10-01
Expected to finish
2011-07-01
Last updated by the study team
2011-10-13

Who can join

Age: 2 and older, up to 21. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.